Latest Monoclonal antibodies Stories
In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded.
Bacterial recombinant protein expression is now available as a service at Maine Biotechnology Services.
DEERFIELD, Ill., and OSAKA, Japan, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced
Ion Exchange Chromatography Reagents market can be segmented by Companies, Geographies, Applications, Products, Technologies and End Users.
New England Peptide and SISCAPA expand commercialization of mass spec biomarker assays. Gardner, MA (PRWEB) June 11, 2014 Today, New England Peptide,
LA JOLLA, Calif.
New antibodies generated with RuiYi's iCAPS technology to explore GPCR structure and function LA JOLLA, Calif.
- Findings Show Positive Association Between Adherence and Anti-TNF Therapy Compared to Conventional Therapy PARIS, June 11, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Initial clinical experience with 89Zr-labeled anti-PSMA minibody presented LOS ANGELES, June 6, 2014 /PRNewswire/ -- ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering
- A poem in which the author retracts something said in an earlier poem.
More Images (1 images) »